Encarnación Picón

 -Lactam/ -Lactam Inhibitor Combinations for the Treatment of Bacteremia Due to Extended-Spectrum  -Lactamase-Producing Escherichia coli: A Post Hoc Analysis of Prospective Cohorts

Jesús Rodríguez‐Baño, M.D. Navarro, Pilar Retamar et al. · Clinical Infectious Diseases · 2011 · 356 citations · Full text

Community‐Onset Bacteremia Due to Extended‐Spectrum β‐Lactamase–Producing<i>Escherichia coli:</i>Risk Factors and Prognosis

Jesús Rodríguez‐Baño, Encarnación Picón, Paloma Gijón et al. · Clinical Infectious Diseases · 2009 · 324 citations · Full text

Risk Factors and Prognosis of Nosocomial Bloodstream Infections Caused by Extended-Spectrum-β-Lactamase-Producing <i>Escherichia coli</i>

Jesús Rodríguez‐Baño, Encarnación Picón, Paloma Gijón et al. · Journal of Clinical Microbiology · 2010 · 156 citations · Full text

Frequent Esbl, Antimicrobial Susceptibility, Antibiotics +14

Comparative assessment of inoculum effects on the antimicrobial activity of amoxycillin-clavulanate and piperacillin-tazobactam with extended-spectrum β-lactamase-producing and extended-spectrum β-lactamase-non-producing Escherichia coli isolates.

Lorena López‐Cerero, Encarnación Picón, C. Morillo et al. · Clinical Microbiology and Infection · 2009 · 80 citations

Inoculum Effects, Comparative Assessment, Antimicrobial Susceptibility +10

Impact of changes in CLSI and EUCAST breakpoints for susceptibility in bloodstream infections due to extended-spectrum β-lactamase-producing Escherichia coli

Jesús Rodríguez‐Baño, Encarnación Picón, M.D. Navarro et al. · Clinical Microbiology and Infection · 2011 · 39 citations

Antimicrobial Resistance Gene, Eucast Breakpoints, Health Sciences +12